Evaluation of the Pro-inflammatory Cytokine Tumor Necrosis Factor-α in Adolescents with Polycystic Ovary Syndrome

Journal of Pediatric and Adolescent Gynecology

Volumn 27, Issue 6, 2014, Pages 356-359

  Pawelczak, Melissa ^a   Rosenthal, Jamie ^a   Milla, Sarah ^a   Liu, Ying Hua ^a   Shah, Bina ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adolescents; Polycystic ovary syndrome; Tumor necrosis factor (TNF )

Indexed keywords

CYTOKINE; GLUCOSE; INSULIN; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; TUMOR NECROSIS FACTOR;

ADOLESCENT; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BLOOD SAMPLING; BODY MASS; CHRONIC INFLAMMATION; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ECHOGRAPHY; FEMALE; FEMALE INFERTILITY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; IMMUNOASSAY; INSULIN RESISTANCE; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OVARY POLYCYSTIC DISEASE; RETROSPECTIVE STUDY; TESTOSTERONE BLOOD LEVEL; ULTRASOUND SCANNER; BLOOD; COMPLICATION; DIAGNOSTIC IMAGING; INFLAMMATION; OVARY FOLLICLE; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; BIOMARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERANDROGENISM; INFLAMMATION; INSULIN; INSULIN RESISTANCE; OBESITY; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA; ULTRASONOGRAPHY;

EID: 84911911782     PISSN: 10833188     EISSN: 18734332     Source Type: Journal    
DOI: 10.1016/j.jpag.2014.01.104     Document Type: Article

References (26)

1. Norman R.J., Dewailly D., Legro R.S., et al. Polycystic ovary syndrome. Lancet 2007, 370:685.
2. Franks S. Polycystic ovary syndrome. N Engl J Med 1995, 333:853.
3. Legro R.S., Arslanian S.A., Ehrmann D.A., et al. Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2013, 98:4565.
4. Deligeoroglou E., Vrachnis N., Athanasopoulos N., et al. Mediators of chronic inflammation in polycystic ovarian syndrome. Gynecol Endocrinol 2012, 28:974.
5. Sun L., Hu W., Liu Q., et al. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res 2012, 11:2937.
6. Xiong Y.L., Liang X.Y., Yang X., et al. Low-grade chronic inflammation in the peripheral blood and ovaries of women with polycystic ovarian syndrome. Eur J Obstet Gynecol Reprod Biol 2011, 159:148.
7. Repaci A., Gambineri A., Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 2011, 335:30.
8. Sathyapalan T., Atkin S.L. Mediators of inflammation in polycystic ovary syndrome in relation to adiposity. Mediators Inflamm 2010, 2010:758656.
9. Diamanti-Kandarakis E., Paterakis T., Kandarakis H.A. Indices of low-grade inflammation in polycystic ovary syndrome. Ann N Y Acad Sci 2006, 1092:175.
10. Duleba A.J., Dokras A. Is PCOS an inflammatory process?. Fertil Steril 2012, 97:7.
11. Fulghesu A.M., Sanna F., Uda S., et al. IL-6 serum levels and production is related to an altered immune response in polycystic ovary syndrome girls with insulin resistance. Mediators Inflamm 2011, 2011:389317.
12. Norman R.J., Brännström M. Cytokines in the ovary: pathophysiology and potential for pharmacological intervention. Pharmacol Ther 1996, 69:219.
13. Brännström M., Norman R.J. Involvement of leukocytes and cytokines in the ovulatory process and corpus luteum function. Hum Reprod 1993, 8:1762.
14. Terranova P.F., Rice V.M. Review: cytokine involvement in ovarian processes. Am J Reprod Immunol 1997, 37:50.
15. Balchak S.K., Marcinkiewicz J.L. Evidence for the presence of tumor necrosis factor alpha receptors during ovarian development in the rat. Biol Reprod 1999, 61:1506.
16. Figueroa F., Davicino R., Micalizzi B., et al. Macrophage secretions modulate the steroidogenesis of polycystic ovary in rats: effect of testosterone on macrophage pro-inflammatory cytokines. Life Sci 2012, 90:733.
17. Quon M.J. Limitations of the fasting glucose to insulin ratio as an index of insulin sensitivity. J Clin Endocrinol Metab 2001, 86:4615.
18. Keskin M., Kurtoglu S., Kendirci M., et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005, 115:e500.
19. Locksley R., Killeen N., Lenardo M. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001, 104:487.
20. Jacob C.O., Lewis G.D., McDevitt H.O. MHC Class II-associated variation in the production of tumor necrosis factor in mice and humans: relevance to the pathogenesis of autoimmune diseases. Immunol Res 1991, 10:156.
21. Fauci A.S., Schnittman S.M., Poli G., et al. Mechanisms in human immunodeficiency virus (HIV) Infection. Ann Intern Med 1991, 114:678.
22. Muthukumaran N., Miletti-González K.E., Ravindranath A.K., et al. Tumor necrosis factor-alpha differentially modulates CD44 expression in ovarian cancer cells. Mol Cancer Res 2006, 4:511.
23. Szlosarek P.W., Grimshaw M.J., Kulbe H., et al. Expression and regulation of tumor necrosis factor alpha in normal and malignant ovarian epithelium. Mol Cancer Ther 2006, 5:382.
24. Hassan M.I., Kassim S.K., Laban M., et al. Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue. Anticancer Res 1990, 19:5657.
25. Dossus L., Becker S., Rinaldi S., et al. Tumor necrosis factor (TNF)- α, soluble TNF receptors and endometrial cancer risk: the EPIC study. Int J Cancer 2011, 129:2032.
26. Chittenden B.G., Fullerton G., Maheshwari A., et al. Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review. Reprod Biomed Online 2009, 19:398.